Home » Newsletters » BioWorld Science

BioWorld Science

April 30, 2004

View Archived Issues

Further data on efficacy of solifenacin for overactive bladder therapy

INO-1001 ameliorates ischemia/reperfusion injury in a canine heart transplant model

FK-778 reduces expression of adhesion molecules in preclinical models of allograft rejection

Novartis presents new S1P agonists with immunomodulating properties

Novel p38 inhibitors identified at Boehringer Ingelheim

AACAP guidelines recommend Strattera as first-line therapy for ADHD

Cubane-based mGluR modulators with activity in stroke and anxiety models

Novartis claims new substance P antagonists and their use

Novel protein kinase inhibitors in early development at Aventis

Novel TGF-beta inhibitors identified by Scios researchers

New PPARalpha/PPARgamma agonists prepared and tested at Roche

European Commission approved Sanofi-Synthelabo/Aventis tie-up

First two phase III trials for ferumoxytol commence

Mycamine NDA submitted for esophageal candidiasis

R&D highlights from the 3rd Annual Global Biotech Forum for Investing & Partnering: Zelos

R&D highlights from the 3rd Annual Global Biotech Forum for Investing & Partnering: Therion

Curcumin effective against human retinal endothelial cell proliferation

Second stage entered in phase I study of SPL-7013

Esteve takes marketing rights to Wilex's Rencarex in Southern Europe

Zimmer Holdings completes acquisition of Implex

European approval for Velcade in multiple myeloma

Praecis and Schering AG enter Plenaxis commercialization agreement

German approval for Niaspan

Elan completes sale of Zonegran to Eisai

Bristol-Myers Squibb and Merck & Co enter global alliance for muraglitazar

Positive data for HuMax-CD4 in phase II CTCL studies

Chugai and Roche enter second research collaboration

M-40403 improves analgesic profile of morphine in phase II trial

Natalizumab reported safe and effective in pediatric multiple sclerosis

Therapeutic benefits of ruboxistaurin mesilate in patients with DPN

Adjunctive therapy with lerdelimumab after phacotrabeculectomy beneficial for IOP

Vaccines suggested as an alternative for treating glaucoma

Involvement of COX-2 and MMP-9 in nitric oxide-mediated inflammation in animal model of migraine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...